These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 7628787)
1. [The effect of lactitol (NS-4) on the concentrations of ammonia and amino acids in blood and cerebrospinal fluid in Eck fistula (portacaval-shunted) dogs]. Watanabe M; Ozaki T; Hirata Y; Yoshikuni Y; Kimura K; Suzuki K; Sato S Nihon Yakurigaku Zasshi; 1995 May; 105(5):389-402. PubMed ID: 7628787 [TBL] [Abstract][Full Text] [Related]
2. Effect of ammonia on plasma and cerebrospinal fluid amino acids in dogs with and without portacaval anastomoses. Schäfer K; Ukida M; Steffen C; Bode C; Zelder O; Bode JC Res Exp Med (Berl); 1985; 185(1):35-44. PubMed ID: 2857496 [TBL] [Abstract][Full Text] [Related]
3. [Ameliorating effect of lactitol on experimental hepatic encephalopathy in Eck fistula dogs]. Watanabe M; Ozaki T; Mushiroi T; Ukai Y; Ueda F; Kimura K; Katoh M; Matsumoto A; Kotani E; Itoh S Nihon Yakurigaku Zasshi; 1995 May; 105(5):403-13. PubMed ID: 7628788 [TBL] [Abstract][Full Text] [Related]
4. [Effect of lactitol (NS-4) on the increase in blood and brain ammonia concentration and on coma in newly developed rat models of hepatic coma]. Watanabe M; Ozaki T; Hirata Y; Yoshikuni Y; Kimura K Nihon Yakurigaku Zasshi; 1995 Feb; 105(2):97-109. PubMed ID: 7737597 [TBL] [Abstract][Full Text] [Related]
5. Mechanism for lowering blood ammonia levels by lactitol. Watanabe M; Ozaki T; Hirata Y; Yamamoto O; Niida H; Ueda F; Yoshikuni Y; Kimura K Jpn J Pharmacol; 1995 Apr; 67(4):369-74. PubMed ID: 7650870 [TBL] [Abstract][Full Text] [Related]
6. [Study of the ameliorating effects of an enteral nutrient for liver failure on hepatic encephalopathy: effects of SF-1008C on plasma and brain free amino acids, intracerebral amine concentrations and electroencephalogram in portacaval shunted rats with ammonia loading]. Kido Y; Sugiyama K; Nakao S; Kashiyama E; Suda T; Miyamoto G; Shimizu T; Shintani S; Kohri H Nihon Yakurigaku Zasshi; 1986 Jul; 88(1):47-56. PubMed ID: 3093339 [TBL] [Abstract][Full Text] [Related]
7. Amino acid, ammonia and neurotransmitter concentrations in hepatic encephalopathy: serial analysis in plasma and cerebrospinal fluid during treatment with an adapted amino acid solution. Rössle M; Luft M; Herz R; Klein B; Lehmann M; Gerok W Klin Wochenschr; 1984 Sep; 62(18):867-75. PubMed ID: 6149332 [TBL] [Abstract][Full Text] [Related]
8. Lactitol in prevention of recurrent episodes of hepatic encephalopathy in cirrhotic patients with portal-systemic shunt. Riggio O; Balducci G; Ariosto F; Merli M; Pieche U; Pinto G; Tremiterra S; Ziparo V; Capocaccia L Dig Dis Sci; 1989 Jun; 34(6):823-9. PubMed ID: 2656134 [TBL] [Abstract][Full Text] [Related]
9. Reduced somatostatin-like immunoreactivity in the brain of dogs with an Eck fistula. Tateishi K; Sato S; Kato A; Suzuki K; Miura Y; Matsuoka Y Regul Pept; 1987 Sep; 18(5-6):277-86. PubMed ID: 2890185 [TBL] [Abstract][Full Text] [Related]
10. Lactitol in the treatment of chronic hepatic encephalopathy: an open comparison with lactulose. Lanthier PL; Morgan MY Gut; 1985 Apr; 26(4):415-20. PubMed ID: 3979914 [TBL] [Abstract][Full Text] [Related]
11. Comparative modes of action of lactitol and lactulose in the treatment of hepatic encephalopathy. Patil DH; Westaby D; Mahida YR; Palmer KR; Rees R; Clark ML; Dawson AM; Silk DB Gut; 1987 Mar; 28(3):255-9. PubMed ID: 3570029 [TBL] [Abstract][Full Text] [Related]
12. Current state of knowledge of hepatic encephalopathy (part III): non-absorbable disaccharides. Morgan MY Metab Brain Dis; 2016 Dec; 31(6):1361-1364. PubMed ID: 27638474 [TBL] [Abstract][Full Text] [Related]
13. Alterations in plasma and CSF amino acids, amines and metabolites in hepatic coma. Smith AR; Rossi-Fanelli F; Ziparo V; James JH; Perelle BA; Fischer JE Ann Surg; 1978 Mar; 187(3):343-50. PubMed ID: 637594 [TBL] [Abstract][Full Text] [Related]
14. [1st use of lactitol in the treatment of porto-systemic encephalopathy]. Bircher J; Bührer M; Franz K; van Velthuijsen JA Schweiz Med Wochenschr; 1982 Sep; 112(38):1306-7. PubMed ID: 7134954 [TBL] [Abstract][Full Text] [Related]
15. Lactitol in the treatment of chronic hepatic encephalopathy--a randomized cross-over comparison with lactulose. Riggio O; Balducci G; Ariosto F; Merli M; Tremiterra S; Ziparo V; Capocaccia L Hepatogastroenterology; 1990 Oct; 37(5):524-7. PubMed ID: 2253931 [TBL] [Abstract][Full Text] [Related]
16. Increased blood-brain transport of tryptophan after portacaval anastomoses in germ-free rats. Jeppsson B; James JH; Hummel RP; Brenner W; West R; Fischer JE Metabolism; 1983 Jan; 32(1):4-8. PubMed ID: 6848895 [TBL] [Abstract][Full Text] [Related]
17. Treatment of porto-systemic encephalopathy with lactitol verus lactulose: a randomized controlled study. Pai CH; Huang YS; Jeng WC; Chan CY; Lee SD Zhonghua Yi Xue Za Zhi (Taipei); 1995 Jan; 55(1):31-6. PubMed ID: 7712392 [TBL] [Abstract][Full Text] [Related]
18. Effects of lactitol [correction of lactilol] on hepatic encephalopathy and plasma amino-acid imbalance. Trovato GM; Catalano D; Carpinteri G; Runcio N; Mazzone O Recenti Prog Med; 1995; 86(7-8):299-303. PubMed ID: 7569287 [TBL] [Abstract][Full Text] [Related]
19. The effects of ammonia and portal-systemic shunting on brain metabolism, neurotransmission and intracranial hypertension in hyperammonaemia-induced encephalopathy. Vogels BA; van Steynen B; Maas MA; Jörning GG; Chamuleau RA J Hepatol; 1997 Feb; 26(2):387-95. PubMed ID: 9059962 [TBL] [Abstract][Full Text] [Related]
20. Protective effect of L-carnitine in ammonia-precipitated encephalopathy in the portacaval shunted rat. Therrien G; Rose C; Butterworth J; Butterworth RF Hepatology; 1997 Mar; 25(3):551-6. PubMed ID: 9049197 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]